Microbial tryptophan catabolites in health and disease

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Roager, Henrik M ^a,b   Licht, Tine R ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AROMATIC HYDROCARBON RECEPTOR; GASTROINTESTINAL HORMONE; TRYPTAMINE; TRYPTOPHAN;

AMINO ACID; CATABOLISM; DIGESTIVE SYSTEM; HEALTH STATUS; METABOLITE; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; PROTEOMICS;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CATABOLISM; GASTROINTESTINAL MOTILITY; HEALTH; HORMONE RELEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FUNCTION; LIFE; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN DEGRADATION; REVIEW; SYSTEMIC CIRCULATION; TRYPTOPHAN METABOLISM; ANIMAL; BACTERIUM; DIGESTIVE SYSTEM; DISEASES; METABOLISM;

ANIMALS; BACTERIA; DIGESTIVE SYSTEM; DISEASE; HEALTH; HUMANS; RECEPTORS, ARYL HYDROCARBON; TRYPTOPHAN;

EID: 85051746264     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-05470-4     Document Type: Review

References (118)

1. Tremaroli, V. & Bäckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242–249 (2012)
2. Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Bäckhed, F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell 165, 1332–1345 (2016)
3. Wahlström, A., Sayin, S. I., Marschall, H. U. & Bäckhed, F. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. Cell. Metab. 24, 41–50 (2016)
4. Koeth, R. A. et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576–585 (2013)
5. Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 (2011)
6. Nyangale, E. P., Mottram, D. S. & Gibson, G. R. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J. Proteome Res. 11, 5573–5585 (2012)
7. Evenepoel, P. et al. Amount and fate of egg protein escaping assimilation in the small intestine of humans. Am. J. Physiol. 277, G935–G943 (1999)
8. Gibson, J. A., Sladen, G. E. & Dawson, A. M. Protein absorption and ammonia production: the effects of dietary protein and removal of the colon. Br. J. Nutr. 35, 61–65 (1976)
9. Macfarlane, G. T., Cummings, J. H., Macfarlane, S. & Gibson, G. R. Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system. J. Appl. Bacteriol. 67, 520–527 (1989)
10. Roager, H. M. et al. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat. Microbiol. 1, 16093 (2016). This study demonstrates how a long colonic transit time in humans cause a shift in bacterial catabolism from saccharolytic to proteolytic fermentation
11. Geypens, B. et al. Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut 41, 70–76 (1997)
12. Smith, E. A. & Macfarlane, G. T. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J. Appl. Bacteriol. 81, 288–302 (1996)
13. Vieira-Silva, S. et al. Species–function relationships shape ecological properties of the human gut microbiome. Nat. Microbiol. 1, 16088 (2016)
14. Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372–385 (2013). This study shows for the first time how tryptophan catabolites protect against fungus infections and intestinal inflammation
15. Smith, T. A modification of the method for determining the production of indol by bacteria. J. Exp. Med. 2, 543–547 (1897)
16. Lee, J. H. & Lee, J. Indole as an intercellular signal in microbial communities. FEMS Microbiol. Rev. 34, 426–444 (2010)
17. Elsden, S. R., Hilton, M. G. & Waller, J. M. The end products of the metabolism of aromatic amino acids by clostridia. Arch. Microbiol. 107, 283–288 (1976)
18. Devlin, A. S. et al. Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. Cell. Host. Microbe 20, 709–715 (2016)
19. Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106, 3698–3703 (2009)
20. Williams, B. B. et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell. Host. Microbe 16, 495–503 (2014)
21. Dodd, D. et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551, 648–652 (2017). An elegant study combining genetics and metabolic profiling to characterise a pathway of Clostridium sporogenes that generates aromatic amino acid metabolites
22. Wlodarska, M. et al. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. Cell. Host. Microbe 22, 25–37.e6 (2017)
23. Cervantes-Barragan, L. et al. Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8αα(+) T cells. Science 357, 806–810 (2017). This study reveals that Lactobacillus reuteri via production of indole derivatives, activates AHR which leads to reprogramming of intraepithelial CD4+ T cells into immunoregulatory T cells
24. Wilck, N. et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature 551, 585–589 (2017)
25. Russell, W. R. et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol. Nutr. Food Res. 57, 523–535 (2013). Systematic screening of the ability of colonic bacterial species ferment aromatic amino acids including tryptophan catabolites
26. Aragozzini, F., Ferrari, A., Pacini, N. & Gualandris, R. Indole-3-lactic acid as a tryptophan metabolite produced by Bifidobacterium spp. Appl. Environ. Microbiol. 38, 544–546 (1979)
27. Whitehead, T. R., Price, N. P., Drake, H. L. & Cotta, M. A. Catabolic Pathway for the Production of Skatole and Indoleacetic Acid by the Acetogen Clostridium drakei, Clostridium scatologenes, and Swine Manure. Appl. Environ. Microbiol. 74, 1950–1953 (2008)
28. Darkoh, C., Chappell, C., Gonzales, C. & Okhuysen, P. A rapid and specific method for the detection of indole in complex biological samples. Appl. Environ. Microbiol. 81, 8093–8097 (2015)
29. Lamas, B. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598–605 (2016). The study provides evidence that defects in expression of factors involved in innate immunity, such as CARD9, can alter the microbial tryptophan catabolite production, which can then modify the host immune response
30. Rosas, H. D. et al. A systems-level ‘misunderstanding’: the plasma metabolome in Huntington’s disease. Ann. Clin. Transl. Neurol. 2, 756–768 (2015)
31. Alexeev, E. E. et al. Microbiota-derived indole metabolites promote human and murine intestinal homeostasis through regulation of interleukin-10 receptor. Am. J. Pathol. 188, 1183–1194 (2018)
32. Pavlova, T. et al. Urinary intermediates of tryptophan as indicators of the gut microbial metabolism. Anal. Chim. Acta 987, 72–80 (2017)
33. Magni, G., Amici, A., Emanuelli, M., Raffaelli, N. & Ruggieri, S. Enzymology of NAD+ synthesis. Adv. Enzymol. Relat. Areas Mol. Biol. 73, 135–182 (1999)
34. Hansen, E. B. Redox reactions in food fermentations. Curr. Opin. Food Sci. 19, 98–103 (2018)
35. Van der Meulen, R., Camu, N., Van Vooren, T., Heymans, C. & De Vuyst, L. In vitro kinetic analysis of carbohydrate and aromatic amino acid metabolism of different members of the human colon. Int. J. Food Microbiol. 124, 27–33 (2008)
36. Chen, H. & Fink, G. R. Feedback control of morphogenesis in fungi by aromatic alcohols. Genes Dev. 20, 1150–1161 (2006)
37. Elleuch, L. et al. Bioactive Secondary Metabolites from a New Terrestrial Streptomyces sp. TN262. Appl. Biochem. Biotechnol. 162, 579–593 (2010)
38. Landete, J. M., Rodríguez, H., De las Rivas, B. & Muñoz, R. High-added-value antioxidants obtained from the degradation of wine phenolics by Lactobacillus plantarum. J. Food Prot. 70, 2670–2675 (2007)
39. Jin, M., Xu, C. & Zhang, X. The effect of tryptophol on the bacteriophage infection in high-temperature environment. Appl. Microbiol. Biotechnol. 99, 8101–8111 (2015)
40. Zhu, F. & Jin, M. The effects of a thermophile metabolite, tryptophol, upon protecting shrimp against white spot syndrome virus. Fish. Shellfish. Immunol. 47, 777–781 (2015)
41. Orhan, I., Şener, B., Kaiser, M., Brun, R. & Tasdemir, D. Inhibitory Activity of Marine Sponge-Derived Natural Products against Parasitic Protozoa. Mar. Drugs 8, 47–58 (2010)
42. Honoré, A. H. et al. Metabolic footprinting for investigation of antifungal properties of Lactobacillus paracasei. Anal. Bioanal. Chem. 408, 83–96 (2016)
43. Narayanan, T. K. & Rao, G. R. Beta-indoleethanol and beta-indolelactic acid production by Candida species: their antibacterial and autoantibiotic action. Antimicrob. Agents Chemother. 9, 375–380 (1976)
44. Lee, J.-H. et al. Indole-associated predator-prey interactions between the nematode Caenorhabditis elegans and bacteria. Environ. Microbiol. 19, 1776–1790 (2017)
45. Bommarius, B. et al. A Family of Indoles Regulate Virulence and Shiga Toxin Production in Pathogenic E. coli. PLoS ONE 8, e54456 (2013)
46. Cheng, Y. et al. Aryl Hydrocarbon Receptor Activity of Tryptophan Metabolites in Young Adult Mouse Colonocytes. Drug Metab. Dispos. 43, 1526–1543 (2015)
47. Hubbard, T. D. et al. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep. 5, 12689 (2015). This paper shows adaptation of human AHR to bind indole as a selective human AHR agonist, suggesting a degree of evolutionary adaption by the AHR
48. Stockinger, B., Di Meglio, P., Gialitakis, M. & Duarte, J. H. The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32, 403–432 (2014)
49. Quintana, F. J. et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65–71 (2008)
50. Bessede, A. et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511, 184–190 (2014)
51. Gandhi, R. et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 11, 846–853 (2010)
52. Poland, A., Palen, D. & Glover, E. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46, 915–921 (1994)
53. Ramadoss, P. & Perdew, G. H. Use of 2-Azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a Probe to Determine the Relative Ligand Affinity of Human versus Mouse Aryl Hydrocarbon Receptor in Cultured Cells. Mol. Pharmacol. 66, 129–136 (2004)
54. Jin, U.-H. et al. Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities. Mol. Pharmacol. 85, 777–788 (2014)
55. Takamura, T. et al. Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis. Immunol. Cell Biol. 89, 817–822 (2011)
56. Noack, M. & Miossec, P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun. Rev. 13, 668–677 (2014)
57. Sonowal, R. et al. Indoles from commensal bacteria extend healthspan. Proc. Natl Acad. Sci. USA 114, E7506–E7515 (2017)
58. Bansal, T., Alaniz, R. C., Wood, T. K. & Jayaraman, A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc. Natl Acad. Sci. USA 107, 228–233 (2010). The first study to propose that indole strengthens epithelial cell-barrier properties and attenuate inflammation
59. Shimada, Y. et al. Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS ONE 8, e80604 (2013)
60. Venkatesh, M. et al. Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4. Immunity 41, 296–310 (2014)
61. Garg, A. et al. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation. J. Pharmacol. Exp. Ther. 359, 91–101 (2016)
62. Jennis, M. et al. Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo. Neurogastroenterol. Motil. 30, e13178 (2017)
63. Chimerel, C. et al. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 9, 1202–1208 (2014). This paper demonstrates that GLP-1 secretion from enteroendocrine L cells is modulated by exposure to indole at concentrations similar to those found in the human large intestine
64. Holst, J. J. The Physiology of Glucagon-like Peptide 1. Physiol. Rev. 87, 1409–1439 (2007)
65. de Mello, V. D. et al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Sci. Rep. 7, 46337 (2017)
66. Abildgaard, A., Elfving, B., Hokland, M., Wegener, G. & Lund, S. The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour. Arch. Physiol. Biochem. 1–7, https://doi.org/10.1080/13813455.2017.1398262 (2017)
67. Reimann, F., Tolhurst, G. & Gribble, F. M. G-Protein-Coupled Receptors in Intestinal Chemosensation. Cell. Metab. 15, 421–431 (2012)
68. Husted, A. S., Trauelsen, M., Rudenko, O., Hjorth, S. A. & Schwartz, T. W. GPCR-Mediated Signaling of Metabolites. Cell. Metab. 25, 777–796 (2017)
69. Takaki, M., Mawe, G. M., Barasch, J. M., Gershon, M. D. & Gershon, M. D. Physiological responses of guinea-pig myenteric neurons secondary to the release of endogenous serotonin by tryptamine. Neuroscience 16, 223–240 (1985)
70. Mawe, G. M. & Hoffman, J. M. Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 10, 473–486 (2013)
71. Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57–62 (2015)
72. Lacy, B. E., Chey, W. D. & Lembo, A. J. New and Emerging Treatment Options for Irritable Bowel Syndrome. Gastroenterol. Hepatol. (N. Y) 11, 1–19 (2015)
73. Png, C. W. et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420–2428 (2010)
74. Joossens, M. et al. Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives. Gut 60, 631–637 (2011)
75. Tailford, L. E. et al. Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation. Nat. Commun. 6, 7624 (2015)
76. Hoffmann, T. W. et al. Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. Isme. J. 10, 460–477 (2016)
77. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010)
78. Sagheddu, V., Patrone, V., Miragoli, F., Puglisi, E. & Morelli, L. Infant Early Gut Colonization by Lachnospiraceae: High Frequency of Ruminococcus gnavus. Front. Pediatr. 4, 57 (2016)
79. Schirmer, M. et al. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell 167, 1125–1136.e8 (2016)
80. Chyan, Y. J. et al. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J. Biol. Chem. 274, 21937–21942 (1999)
81. Hwang, I. K. et al. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. J. Neurosci. Res. 87, 2126–2137 (2009)
82. Karbownik, M., Stasiak, M., Zasada, K., Zygmunt, A. & Lewinski, A. Comparison of potential protective effects of melatonin, indole-3-propionic acid, and propylthiouracil against lipid peroxidation caused by potassium bromate in the thyroid gland. J. Cell. Biochem. 95, 131–138 (2005)
83. Karbownik, M., Stasiak, M., Zygmunt, A., Zasada, K. & Lewiński, A. Protective effects of melatonin and indole-3-propionic acid against lipid peroxidation, caused by potassium bromate in the rat kidney. Cell. Biochem. Funct. 24, 483–489 (2006)
84. Joshi, G. & Johnson, J. A. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat. CNS Drug Discov. 7, 218–229 (2012)
85. Lu, M.-C. et al. An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis. Sci. Rep. 6, 26585 (2016)
86. Krishnan, S. et al. Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages. Cell Rep. 23, 1099–1111 (2018)
87. Kado, S. et al. Aryl hydrocarbon receptor signaling modifies Toll-like receptor-regulated responses in human dendritic cells. Arch. Toxicol. 91, 2209–2221 (2016)
88. Jin, U.-H. et al. Short Chain Fatty Acids Enhance Aryl Hydrocarbon (Ah) Responsiveness in Mouse Colonocytes and Caco-2 Human Colon Cancer Cells. Sci. Rep. 7, 10163 (2017)
89. Banoglu, E., Jha, G. G. & King, R. S. Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate. Eur. J. Drug Metab. Pharmacokinet. 26, 235–240 (2001)
90. Wu, I.-W. et al. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant. 26, 938–947 (2011)
91. Kim, H. Y. et al. Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD). Sci. Rep. 7, 3057 (2017)
92. Schroeder, J. C. et al. The Uremic Toxin 3-Indoxyl Sulfate Is a Potent Endogenous Agonist for the Human Aryl Hydrocarbon Receptor. Biochemistry 49, 393–400 (2010)
93. Motojima, M., Hosokawa, A., Yamato, H., Muraki, T. & Yoshioka, T. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cells. Kidney Int. 63, 1671–1680 (2003)
94. Niwa, T. & Ise, M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J. Lab. Clin. Med. 124, 96–104 (1994)
95. Dou, L. et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int. 65, 442–451 (2004)
96. Dou, L. et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J. Thromb. Haemost. 5, 1302–1308 (2007)
97. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012)
98. Bergström, A. et al. Establishment of intestinal microbiota during early life: A longitudinal, explorative study of a large cohort of Danish infants. Appl. Environ. Microbiol. 80, 2889–2900 (2014)
99. Laursen, M. F. et al. Infant Gut Microbiota Development Is Driven by Transition to Family Foods Independent of Maternal Obesity. mSphere 1, e00069–15 (2016)
100. Laursen, M. F., Bahl, M. I., Michaelsen, K. F. & Licht, T. R. First Foods and Gut Microbes. Front. Microbiol. 8, 356 (2017)
101. Bäckhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell. Host. Microbe 17, 690–703 (2015)
102. Bazanella, M. et al. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome. Am. J. Clin. Nutr. 106, 1274–1286 (2017)
103. Kiss, E. A. et al. Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles. Sci. (80-.). 334, 1561–1565 (2011)
104. Gomez de Aguero, M. et al. The maternal microbiota drives early postnatal innate immune development. Sci. (80-.). 351, 1296–1302 (2016). First study to suggest that tryptophan catabolites may shape the composition and function of early postnatal immunity
105. Hill, C. J. et al. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome 5, 21 (2017)
106. Fischer, D. D. et al. Protein Malnutrition Alters Tryptophan and Angiotensin-Converting Enzyme 2 Homeostasis and Adaptive Immune Responses in Human Rotavirus-Infected Gnotobiotic Pigs with Human Infant Fecal Microbiota Transplant. Clin. Vaccin. Immunol. 24, e00172–17 (2017)
107. Saraf, M. K. et al. Formula diet driven microbiota shifts tryptophan metabolism from serotonin to tryptamine in neonatal porcine colon. Microbiome 5, 77 (2017)
108. Nikolaus, S. et al. Increased Tryptophan Metabolism is Associated With Activity of Inflammatory Bowel Diseases. Gastroenterology 153, 1504–1516.e2 (2017)
109. Hisamatsu, T. et al. Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease. PLoS ONE 7, e31131 (2012)
110. Gupta, N. K. et al. Serum analysis of tryptophan catabolism pathway: correlation with Crohn’s disease activity. Inflamm. Bowel Dis. 18, 1214–1220 (2012)
111. Jansson, J. et al. Metabolomics reveals metabolic biomarkers of Crohn’s disease. PLoS ONE 4, e6386 (2009)
112. Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477–481 (2012)
113. Monteleone, I. et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141, 237–248 (2011). 248.e1
114. Goettel, J. A. et al. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. Cell Rep. 17, 1318–1329 (2016)
115. Whitfield-Cargile, C. M. et al. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy. Gut Microbes 7, 246–261 (2016)
116. Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586–597 (2016). The study provides evidence that tryptophan metabolites modulate the activity of central nervous system resident cells and suppress neuroinflammation
117. Kaye, J. et al. Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. 113, E6145–E6152 (2016)
118. Honeyfield, D. C. & Carlson, J. R. Effect of Indoleacetic Acid and Related Indoles on Lactobacillus sp. Strain 11201 Growth, Indoleacetic Acid Catabolism, and 3-Methylindole Formation. Appl. Environ. Microbiol. 56, 1373–1377 (1990)